These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11794866)

  • 1. Can delavirdine substitute for ritonavir?
    TreatmentUpdate; 2001; 13(7):8. PubMed ID: 11794866
    [No Abstract]   [Full Text] [Related]  

  • 2. Delavirdine increases drug exposure of ritonavir-boosted protease inhibitors.
    Harris M; Alexander C; O'Shaughnessy M; Montaner JS
    AIDS; 2002 Mar; 16(5):798-9. PubMed ID: 11964540
    [No Abstract]   [Full Text] [Related]  

  • 3. Delavirdine/protease inhibitor interactions.
    Gilden D
    GMHC Treat Issues; 1996 Sep; 10(9):11-2. PubMed ID: 11363839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delavirdine in rescue regimens.
    TreatmentUpdate; 2002; 14(4):6. PubMed ID: 12064317
    [No Abstract]   [Full Text] [Related]  

  • 5. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
    Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
    AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
    [No Abstract]   [Full Text] [Related]  

  • 7. Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
    Gulick RM; Hu XJ; Fiscus SA; Fletcher CV; Haubrich R; Cheng H; Acosta E; Lagakos SW; Swanstrom R; Freimuth W; Snyder S; Mills C; Fischl M; Pettinelli C; Katzenstein D
    J Infect Dis; 2002 Sep; 186(5):626-33. PubMed ID: 12195349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 9. Ritonavir (Norvir).
    Res Initiat Treat Action; 2000 Mar; 6(1):26-7. PubMed ID: 11708183
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency.
    Resino S; Bellón JM; Muñoz-Fernández MA;
    J Antimicrob Chemother; 2006 Mar; 57(3):579-82. PubMed ID: 16446377
    [No Abstract]   [Full Text] [Related]  

  • 11. Ritonavir (Norvir) and methadone.
    Treat Rev; 1998; (No 28):15. PubMed ID: 11365421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible fatal interaction between protease inhibitors and methamphetamine.
    Hales G; Roth N; Smith D
    Antivir Ther; 2000 Mar; 5(1):19. PubMed ID: 10846588
    [No Abstract]   [Full Text] [Related]  

  • 13. Marked hyperlipidaemia on ritonavir therapy.
    Sullivan AK; Nelson MR
    AIDS; 1997 Jun; 11(7):938-9. PubMed ID: 9189227
    [No Abstract]   [Full Text] [Related]  

  • 14. Ritonavir, triglycerides, and pancreatitis.
    Perry RC; Cushing HE; Deeg MA; Prince MJ
    Clin Infect Dis; 1999 Jan; 28(1):161-2. PubMed ID: 10028103
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar; 20(2):5-6. PubMed ID: 18661644
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 17. Delavirdine (Rescriptor).
    Res Initiat Treat Action; 2000 Mar; 6(1):20-1. PubMed ID: 11708180
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS.
    Mirete G; Masiá M; Gutiérrez F; Mora A; Escolano C; Maestre A
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):810-1. PubMed ID: 9923528
    [No Abstract]   [Full Text] [Related]  

  • 20. Ritonavir-boosted protease inhibitors: impact of ritonavir on toxicities in treatment-experienced patients.
    Sension M; Piliero PJ
    J Assoc Nurses AIDS Care; 2007; 18(1):36-47. PubMed ID: 17338984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.